INFORMATION BY CANCER TYPE

Lymphoma

When the Bell Tolls for Another Loss to Cancer
BY BY Felicia Mitchell
When we are surviving cancer, when we want to see everybody else survive it too, another death is hard to take. When somebody passes, we are reminded of our own mortality—and distant losses—even as we mourn. Poetry helps.
Expert Discusses the Changing Landscape of Mantle Cell Lymphoma Treatment
BY BY Danielle Bucco
Peter Martin, M.D., discusses the evolving field of mantle cell lymphoma treatment.
Agent Granted Priority Review to Treat Non-Hodgkin Lymphoma
BY BY Silas Inman
Axicabtagene ciloleucel (KTE-C19; axi-cel) was granted a priority review by the Food and Drug Administration (FDA) for the treatment of transplant-ineligible patients with relapsed or refractory non-Hodgkin lymphoma (NHL). 
Stem Cell Transplant Benefit Limited for Some Patients With Lymphoma
BY BY Angelica Welch
There is currently no uniform procedure for patients with double-hit lymphoma (DHL) that prolongs benefit. Some patients receive autologous stem-cell transplantation to reduce the risk of relapse, but the jury is still out on the impact that it has.
 
Copanlisib Granted Priority Review for Lymphoma
BY BY Jason M. Broderick
Copanlisib was granted a priority review designation by the Food and Drug Administratioin (FDA) for the treatment of patients with relapsed/refractory follicular lymphoma who had at least two therapies beforehand, according to Bayer, the manufacturer of the drug.
 
New Rituxan Results as FDA Decision Nears for Lymphoma
BY BY Jason Harris
There were nearly identical response rates and toxicity with subcutaneous administration of Rituxan (rituximab) and IV administration of the drug to treat follicular lymphoma in the first-line setting, according to results from the phase 3 SABRINA trial that were published in The Lancet Haematology.
Seeking a Complete Response in Hematologic Cancers
BY BY Jason Harris
Experts discuss how to have the best chances for a complete response for patients with chronic lymphocytic leukemia (CLL) who developed Hodgkin lymphoma (HL). 
Exploring Genetic Testing for Mantle Cell Lymphoma
BY BY Gina Columbus
Grzegorz S. Nowakowski, M.D., discusses the potential for genetic testing for patients with mantle cell lymphoma. 
Going Broke Paying for Cancer Medications? This May Help
BY BY Ryan Hamner
How I saved big on costly prescription medications for cancer treatment.
Special Feature
Share Your Art
Talk about this article with other patients, caregivers, and advocates in the Lymphoma CURE discussion group.
Search Cancer Drugs & Terms
Treatment
Information about treatment, including surgery, chemotherapy, radiation therapy, immunotherapy, and vaccine therapy
Adult Hodgkin Lymphoma Treatment (PDQ®)
Expert-reviewed information summary about the treatment of adult Hodgkin lymphoma.
Adult Non-Hodgkin Lymphoma Treatment (PDQ®)
Expert-reviewed information summary about the treatment of adult non-Hodgkin lymphoma.
AIDS-Related Lymphoma Treatment (PDQ®)
Expert-reviewed information summary about the treatment of AIDS-Related Lymphoma.
Childhood Hodgkin Lymphoma Treatment (PDQ®)
Expert-reviewed information summary about the treatment of childhood Hodgkin lymphoma.
Childhood Non-Hodgkin Lymphoma Treatment (PDQ®)
Expert-reviewed information summary about the treatment of childhood non-Hodgkin lymphoma.
Primary CNS Lymphoma Treatment (PDQ®)
Expert-reviewed information summary about the treatment of primary CNS lymphoma.
x